Popular Post Eva-Beatrice Posted December 5, 2018 Popular Post Share Posted December 5, 2018 (edited) The City of Books - a sacred realm separate from our own, under the divine protection of the Witch Senate. Here, countless books are stored, each one containing an entire world. In some instances, they may only contain knowledge of a specific thing, or group of things if they've been deemed important enough. Upon one of the many bookshelves within a small, semicircular room, rests one such book. The title on the spine read "The Legend of Hinamizawa." The following passage specifically relates to Hinamizawa Syndrome. History Hinamizawa Syndrome is a psychiatric disease found exclusively in citizens, or sometimes visitors, of Hinamizawa, Gifu Prefecture, Japan. The disease was first discovered by a local researcher named Hifumi Takano in the year 1963. Takano would soon write a report regarding the history of Hinamizawa and the supposed disease plaguing its residents, with the goal of making knowledge of the disease public and to secure funds for researching its treatment. Part of Takano's report proposed that a member of the Imperial Japanese Army, one from Hinamizawa, was afflicted with Hinamizawa Syndrome. As a result of the worsening disease, this soldier fired at the Chinese National Revolutionary Army, triggering the second Sino-Japanese war in the year 1937. Several government officials at the time rejected Takano's report, as accepting his proposal would mean having to take responsibility for the Marco Polo Bridge Incident, which "Tokyo" had no intention of doing. Shortly after Hifumi Takano's death, his adopted granddaughter, Miyo Takano, took over her father's research of Hinamizawa Syndrome. She managed to secure funding from a "Tokyo" official named Nomura. Using this money, Takano joined with Kyousuke Irie and formed the Irie Institution, to further research the disease from within Hinamizawa itself. Use As A Biological Weapon "Tokyo" decided Japan needed a threatening biological weapon to compete with the world's emergent nuclear powers at the time. As a result, "Tokyo" commissioned research for both the cure and infliction of Hinamizawa Syndrome. In 1980, Miyo Takano developed H-173, a drug designed to induce Level 5 symptoms on any infected person. H-173 has since been used several times by "Tokyo" and later the Witch Council of Rokkenjima to assassinate an unknown number of targets. In 2018, an airborne version of H-173 was successfully developed, currently in use as a form of bioterrorism by the Rokkenjima Armed Forces. Signs and Symptoms The most common symptoms include anxiety and paranoia, which can force those infected with Hinamizawa Syndrome to commit strange and violent acts. Other symptoms include an extreme irritation of the lymph nodes and formication. Progression According to Hifumi Takano's research, Hinamizawa Syndrome has five different stages ranging from Level 1 (weakest) to Level 5 (strongest). Level 1 Almost everyone in Hinamizawa is afflicted with this level of Hinamizawa Syndrome. At this stage, the syndrome is largely dormant and has no effects on everyday life. However, the syndrome can easily escalate when those infected experience stress or anxiety. Level 2 Like the previous level, Level 2 Hinamizawa Syndrome is largely dormant and rarely affects everyday life. Level 3 At Level 3, the mental condition of the afflicted begins to deteriorate. Often times, the afflicted becomes both mentally and emotionally unstable. Level 4 At Level 4, hallucinations and extreme paranoia begin to occur. This can often lead to the afflicted taking drastic or violent measures to protect themselves from imagined enemies. Level 5 At Level 5, the syndrome becomes terminal. Often times, patients will claim hearing an "extra footstep" at this stage. An extreme variant of formication usually occurs, along with extreme irritation of the lymph nodes. This often leads to the afflicted clawing at their own throat until death. As formication can result from excessive use of amphetamines, those who die from Hinamizawa Syndrome are sometimes believed to have died from narcotic use. Causes Queen Carrier Theory Hifumi Takano identified an antibody of Hinamizawa Syndrome in the blood of members of the Furude family. He used this to designate the family as the as the "queen carriers" of the parasite, with the status of "queen carrier" falling upon the latest born female. He theorized that 48 hours after the death of the queen carrier, the parasites afflicting the villagers would aggravate the symptoms of Hinamizawa Syndrome, forcing everyone in Hinamizawa into Level 5 status. To counteract this, Takano created Emergency Manual #34, a contingency plan to wipe out the entire village in the event that a queen carrier should die. Although the discovery of an antibody found in the Furude family's blood was true, the Queen Carrier Theory has since been proven incorrect. Treatment The first treatment for Hinamizawa Syndrome, C-103, was created in 1980 by Kyousuke Irie. Developed from the previously discovered antibody in Rika Furude's blood, the drug was successful in reducing Hinamizawa Syndrome from Level 5 to Level 3. However, in order to keep the syndrome subdued, the drug had to be received three times a day via injection. If the drug wasn't taken three times a day, Hinamizawa Syndrome would relapse to Level 5. In 1982, Irie developed C-117, a slightly more effective drug for treating Hinamizawa Syndrome. Like its predecessor, C-117 could successfully reduce Level 5 Hinamizawa Syndrome to Level 3, though it only required two injections per day, rather than three. In 1983, Irie completed C-120. The most successful drug by far, C-120 could reduce Hinamizawa Syndrome from Level 5 to Level 2 with a single injection. However, the drug had extremely negative side effects when used on individuals who were already at low levels of Hinamizawa Syndrome, such as Level 1 or Level 2. When Level 1 or Level 2 individuals were injected with C-120, they would suffer muscle spasms, extreme irritation of the lymph nodes akin to Level 5, as well as a severe loss of stamina. As a result of these side effects, C-120 is sometimes used as a weapon and was given the nickname Crazy Medicine. In present day, knowledge of Hinamizawa Syndrome remains highly classified by the Witch Council. Research on a complete cure to the disease continues, however thus far, C-120 remains the most successful drug in combating Hinamizawa Syndrome. It is currently unknown whether a complete cure of the disease exists, or is even possible. Content received and slightly altered from: "Hinamizawa Syndrome." When They Cry Wiki, . 20 Apr 2018, 18:24 UTC. 3 Dec 2018, 05:00 <https://wiki.whentheycry.org/w/index.php?title=Hinamizawa_Syndrome&oldid=11000>. Edited February 7, 2019 by Eva-Beatrice 9 8 Quote When the seagulls cried, none were left alive. "If life is a miracle, then death is a certainty." Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.